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Sucking lice (Phthiraptera: Anoplura) are obligate blood-feeding
ectoparasites of placental mammals including humans. Worldwide,
more than 550 species have been described and many are specific to
a particular host species of mammal [1]. Three taxa uniquely
parasitize humans: the head louse, body louse, and crab (pubic)
louse. The body louse, in particular, has epidemiological impor-
tance because it is a vector of the causative agents of three important
human diseases: epidemic typhus, trench fever, and louse-borne
relapsing fever. Since the advent of antibiotics and more effective
body louse control measures in the 1940s, these diseases have
markedly diminished in incidence. However, due to 1) increasing
pediculicide resistance in human lice, 2) reemergence of body louse
populations in some geographic areas and demographic groups, 3)
persistent head louse infestations, and 4) recent detection of body
louse-borne pathogens in head lice, lice and louse-borne diseases are
an emerging problem worldwide. This mini-review is focused on
human body and head lice including their biological relationship to
each other and its epidemiological relevance, the status and
treatment of human louse-borne diseases, and current approaches
to prevention and control of human louse infestations.
Biological, Genetic, and Taxonomic Relationships
between Head Lice and Body Lice
For over a century, scientists have argued about the exact
taxonomic and biological relationships between human head lice
and body lice and, in particular, whether they represent a single
species with two ecotypes or two distinct species [2,3]. The two-
species argument considers the body louse to be Pediculus humanus
and the head louse to be Pediculus capitis (Table 1) (Figure 1A, B, C,
D). The single-species argument treats the body louse as Pediculus
humanus humanus and the head louse as Pediculus humanus capitis.
Further, although the name Pediculus humanus corporis has been used
frequently in the medical literature for the body louse, it is an
invalid name according to the rules of the International
Commission on Zoological Nomenclature. Whether head and
body lice represent distinct species, different subspecies (or strains,
phylotypes, or ecotypes) inhabiting different habitats, or a single
species is more than a taxonomic issue. This is because all well-
investigated outbreaks of louse-transmitted diseases in humans,
including many that have shaped our history, have involved
pathogen transmission by the body louse, not by the head louse
[3]. The recent sequencing and annotation of the small 108 Mb
genome of P. humanus humanus, the chromosome and plasmid of its
symbiotic bacterium, ‘‘Candidatus Riesia pediculicola’’ [4,5], and
the mitochondria of all three human louse taxa [6] have allowed
reevaluation of this argument with potentially important epide-
miological ramifications. The sensitivity of lice to sulfamethoxa-
zole-trimethoprim is thought to reflect its lethality for Riesia, which
lice depend upon for B vitamin synthesis [5,7]. Differences
between head and body lice in the complex developmental
interactions that maintain Riesia between generations have been
described [8], but whether these differences occur in all louse
populations is unknown.
Because of somewhat effective treatment options and increased
societal standards for clothing and body hygiene, body lice are
currently quite rare in most developed countries [9]. However, they
persist or have reemerged in some parts of the world and can also be
common in homeless populations in both developed and developing
nations [9,10]. The number of homeless persons has increased
significantly in recent decades, and the medical welfare of these
people can be difficult to monitor for various reasons [10]. Since
homeless persons may not have a change of clothing or be able to
adequately delouse their clothes, their garb provides nourishing and
unique environments needed for deposition and maintenance of
body louse eggs [9,10]. Explosive increases in populations of body
lice have been reported in crowded refugee camps, especially in
Africa [9]. Conversely, head lice are common and distributed
worldwide with reported infestation prevalences up to 61% [11].
Despite more than 12 years of concerted effort by many
investigators to define genetic markers that clearly differentiate
head and body louse ecotypes as species or subspecies, this goal has
remained elusive [2,3,12–14]. Most of the data from both
mitochondrial and nuclear genes using phylogenetic and popula-
tion genetic methods fail to clearly separate body and head lice,
[2,12–14] indicating that they are conspecific. Although several
mitochondrial genes (cytb, COI, and ND4) appear to separate
head lice into three clades (A, B, C) and place body lice only in
clade A, nuclear genes do not define the same clades, possibly
because of modern recombination between different lineages of
head lice [2,12–14]. Although these clades exhibit some
geographic differences (A is found worldwide, B is found in North
America, Central America, Europe, and Australia, and C in
Nepal, Ethiopia, and Senegal), it is possible these associations may
fail with more extensive sampling of clades B and C [3,15].
Moreover, in both head and body lice, the 37 mitochondrial genes
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are located on 18 minicircles, each containing one to three genes,
and the intergenic regions are variable in each louse likely as a
result of numerous recombination events that make those regions
unsuitable for genetic analysis [6]. The ability of head and body
lice to interbreed, the common movement of each over both head
hair and clothing, and the existence of different color variants of
body lice suggest that there has been substantial opportunity for
generation of novel genetic variants of P. humanus [3,16,17].
Indeed, using more robust microsatellite and multispacer typing
methods, the two studies that attempted to define genetic differences
between head and body louse populations coinfesting the same
persons in Nepal or France emphasized opposite conclusions
regarding the genetic relationships between the two populations
[17,18]. The louse samples in both studies were small but both
clearly demonstrated that individual humans as well as different
individuals from the same site can have lice with different genotypes.
Indeed, the extensive movement of lice over the human body in
populations with both head and body pediculosis makes collections
from each louse ecotype rather difficult. An expanded use of
microsatellites derived from the genome sequence of body lice was
used to differentiate lice from 11 sites in four different geographic
regions into geographic clusters [19]. The hope that the global
movements of people and their lice have not completely obscured the
evolution of lice and the origins of human populations was further
enhanced by development of a qPCR assay that distinguished head
and body lice from 13 countries based on the PHUM540560 gene,
which was expressed differently in transcriptome studies of head and
body lice [20,21]. Although head lice cause medical and psycholog-
ical problems in their own right, the hypothesis that body lice have
emerged repeatedly from head louse populations compounds their
potential epidemiological importance [2,14].
Louse-Borne Pathogens
The incidence of louse-borne diseases has decreased in humans
since the widespread availability of effective antibiotics and
pediculicides. Louse-borne relapsing/recurrent fever (RF), caused
by infection with Borrelia recurrentis, has persisted especially in parts
of Africa, and it has the potential to infect travelers returning to
Europe and North America from endemic regions [22]. Borrelia
recurrentis has been detected recently in 23% of head lice in
Table 1. Selected morphological and biological differences between human head and body lice.
CHARACTERISTIC HEAD LOUSE BODY LOUSE
Color Darker Lighter
Female body length 2.4–3.3 mm 2.4–3.6 mm
Male body length 2.1–2.6 mm 2.3–3.0 mm
Antenna shape Shorter and wider Longer and narrower
3rd antennal segment As long as wide Slightly longer than wide
Abdominal indentations Prominent Not prominent
Apices of paratergal plates Extending into intersegmental membranes Not extending into intersegmental membranes
No. eggs laid by females 4–5/day 8–12/day
Oviposition site Base of head hairs Clothing fibers esp. along seams
Longevity of adults Up to 27 days Up to 60 days
No. bloodmeals 4–10/day 1–5/day
Mitochondrial genetic clades A, B, C A
doi:10.1371/journal.ppat.1003724.t001
Figure 1. Adult body louse and head lice. A. Ventral view of slide-
mounted female head louse; B. Ventral view of slide-mounted male
body louse; C. Dorsal view of ethanol-preserved female head louse; D.
Dorsal view of ethanol-preserved male head louse. All photographs
were taken using a Visionary Digital K2/SC long-distance microscope
(Infinity Photo-Optical Company, Boulder, CO), courtesy of Lorenza
Beati.
doi:10.1371/journal.ppat.1003724.g001
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Ethiopia, but whether head lice serve as a vector is unknown [23].
Although the close genetic relationship between Borrelia duttonii and
B. recurrentis has made their laboratory differentiation by qPCR
difficult [24], the speculation that acquisition of B. duttonii by body
lice could quickly give rise to new strains of B. recurrentis is
uncertain considering the massive loss of protein coding capacity,
plasmids, and plasmid rearrangements of the latter [25,26].
Some other widespread pathogenic bacteria that can be
transmitted to humans by other routes, such as Salmonella typhi
and Serratia marcescens, have been detected in human body lice, and
Acinetobacter baumannii in both head and body lice with the
assumption that lice can probably also transmit these agents to
humans [27,28]. There are also experimental and natural
observations that human lice are not refractory to Yersinia pestis,
the causative agent of plague, and that they may be supplementary
vectors of this agent [29].
Trench Fever
Bartonella quintana is a bacterium that causes trench fever in
humans. It is transmitted by the body louse and possibly by the head
louse [3,9,30]. Infected lice excrete B. quintana onto the skin while
feeding, and the bacteria are either scratched into the skin or rubbed
into mucous membranes. Historically, trench fever was described in
troops in World War I, and again in World War II, but now it is
emerging as a problem in urban homeless populations [3]. B.
quintana has been documented in the homeless and associated body
lice from France, the United States, the Netherlands, Ethiopia,
Japan, Russia, and Mexico and in refugees, prisoners, and rural
populations in Burundi, Rwanda, Zimbabwe, and Peru [30]. B.
quintana has been found in head lice from homeless people without
concurrent body lice infestation [31] as well as in head lice and body
lice of different genotypes in Ethiopia [32]. Humans were thought to
be the sole reservoir for B. quintana, but recently macaque monkeys
and their lice, Pedicinus obtusus, have also been implicated [33,34].
Epidemic (Louse-Borne) Typhus
Rickettsia prowazekii is associated with louse and human
populations in parts of Africa, South America, and Asia [3].
There is no current circulation of this agent between body lice and
humans evident in developed countries of Europe or the Americas.
Outbreaks of primary louse-borne epidemic typhus still occur
infrequently in Africa. Only sporadic cases of flying squirrel– and
tick-associated cases occur in North America as well as rare cases
of recrudescent Brill-Zinsser Disease worldwide. Head lice can
transmit R. prowazekii under laboratory conditions (to naive rhesus
macaques and rabbits), and it has been argued that this louse could
also be involved in the transmission or maintenance of this
pathogen in nature [35], although it has not been detected yet in
head lice in nature. Various populations of head lice infesting
school children worldwide have tested negative for R. prowazekii
and/or B. quintana despite the presence of both pathogens in body
lice from adults in these areas [30]. This potentially indicates the
lack of pathogen transmission in pediatric populations or less than
critical burdens of these pathogens in head lice.
Controlling Head and Body Lice Infestations and
Related Diseases
At present, there are no commercial vaccines against louse-borne
diseases of humans. Therefore, louse-borne disease suppression has
typically involved elimination and control of lice and, secondarily,
treatment of infected patients with doxycycline [9,10,22]. Single-
dose oral administration of doxycycline is most effective in
controlling epidemic typhus when permethrin dusting of clothing
for louse control is not possible. Body louse infestation is typically
associated with poor body and clothing hygiene and crowding,
which enables close person-to-person contact that facilitates the
spread of lice [10]. However, head louse infestations, especially in
developed countries, generally have little to do with hygiene, the
socio-economic status, or race of the individual, and most frequently
affect children between three and 11 years old [11,36–38].
Body louse infestation is diagnosed by finding eggs and crawling
lice in the seams and button holes of clothing, and therefore can be
controlled by laundering and heat treatment of clothing and
wearing permethrin-impregnated clothing [3,9,10,22,23]. Head
lice are frequently viewed as posing no substantial health risk to
infested persons but constitute a social embarrassment to parents
and children. However, head lice and microbial factors, which can
commonly contribute to persistent manifestations including
pruritus, head scratching, anemia, and even more severe
symptoms, need further investigation. An astonishingly large
number of insecticides (Table 2), herbal remedies, occlusive agents,
and head lice repellents have been developed to augment physical
(combing, vacuuming, heat) methods of louse and nit removal
[36–38]. However, while pediculicide resistance to over-the-
counter treatments, particularly to permethrin and other pyrthe-
throid derivatives, as well as to other highly efficacious treatments,
which may require a prescription, is thought to be widespread,
bioassays are difficult to standardize [39] and the correlation of
results of genetic assays to ex vivo assays remains problematic
[40,41]. Ivermectin [42] and spinosad lotions appear to be the
most promising new treatments, while new molecular approaches
to assessments of resistance [20,40,43,44] are making it easier to
survey head louse populations for decreasing responsiveness to
specific therapies. The challenges that the biology of lice pose for
development of customer-friendly, safe, rapid, and effective
chemical treatments for killing both live mobile lice and unhatched
live eggs are daunting. Unfortunately, herbal remedies and
mechanical means do not have the same requirements for
measurement of efficacy. However, creative use of nanoparticle
and silicone formulations as well as development of safe and
effective means to kill head lice in situ offer some expectation that
these difficulties will be surmounted [36–38].
Concluding Remarks
In the 21st century, the prevalence of human louse infestation is
still very high worldwide. New molecular tools have been
developed and applied to head and body louse ecotypes and to
the bacterial agents they transmit. Surprising and novel insights
into the evolution of lice, their bacterial disease agents, and the
epidemiology of louse-borne diseases have stimulated a renewal of
interest in these arthropods. These discoveries may in turn provide
new tools for improved understanding and control of these ancient
and highly personal scourges of humans.
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